Gorlin syndrome Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Clinical Trials

CODY: A Study Evaluating The Safety And Efficacy Of QTORIN 3.9% Sirolimus Topical Gel For The Prevention Of Basal Cell Carcinomas (BCCs) In Patients With Gorlin Syndrome
Condition:   BCCs in Gorlin Syndrome Patients Interventions:   Drug: PTX-022;   Drug: Vehicle comparator Sponsor:   Palvella Therapeutics, Inc. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 19, 2021 Category: Research Source Type: clinical trials

Extension Study of Patidegib Topical Gel, 2% in Subjects With Gorlin Syndrome (Basal Cell Nevus Syndrome)
Condition:   Basal Cell Nevus Syndrome Intervention:   Drug: Patidegib Topical Gel, 2% Sponsor:   PellePharm, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 16, 2020 Category: Research Source Type: clinical trials